References
- Nyren 0. Chemoprevention trials in cancer research—Ethical considerations. Acta Oncol 1998; 37: 235–9.
- The ATBC Cancer Prevention Study Group. The Alpha-To-copherol, Beta-Carotene Lung Cancer Prevention Study: de-sign, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1–10.
- The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smok-ers. New Engl J Med 1994; 330: 1029–35.
- Albanes D, Heinonen OP, Taylor PR, et al. a -Tocopherol and fl-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560–70.
- Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with a-tocopherol and fl-carotene: inci-dence and mortality in a controlled trial 1998; 90: 440–6.
- Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550–9.
- Hakama M. Chemoprevention of cancer. Acta Oncol 1998; 37: 227–30.